Volume 10 Supplement 1
Prolonged air leak following lung resection - does Tri-staplerTM technology improve the incidence?
© Srivastava et al. 2015
Published: 16 December 2015
Prolonged air leak following lung resection leads to delayed discharge and increases risk of infection. The incidence of prolonged air leak (defined as greater than 7 days) is approx. 9% in the U.K. (SCTS Cardiothoracic Surgery database 2011). The Covidien Tri-staplerTM technology (Covidien, Mansfield, MA) claims to improve air leak rates following lung resection through improved vascularity at the suture line. We started using these staplers in August 2012.
To determine if Covidien Tri-staplersTM improve prolonged air leak incidence through comparison with the incidence in previous two years (i.e. August 2010 - July 2012).
The departmental database which collects and validates data prospectively was used to find patients having non-pneumothorax lung resection surgery between August 2010 and July 2014. They were divided into two groups - Group 1 (EndoGIA Autosuture™; August 2010 - July 2012) and Group 2 (Tri-stapler™ device; August 2012 - August 2014). The groups were then compared for preoperative variables and postoperative outcomes.
A total of 401 patients were included - Group 1 with 242 patients (102 males - 42.1%) and Group 2 with 159 patients (72 males - 45.3%). Mean age was 67.5 years (Group1) and 67.6 years (Group2); p = 0.92. COPD incidence was 59 (24.4%) patients in Group 1 and 66 (41.5%) patients in Group 2; p < 0.001. There was no significant differences in the incidence of prolonged air leak in Group 1 (n = 20; 8,3%) and Group 2 (13; 8.2%); p = 0.98. Significant infection prolonging hospital stay was more frequent in Group 1 (n = 17; 7%) than Group 2 (n = 18; 11.3%) but this was not statistically significant (p = 0.15). Mean post-operative stay was similar in both groups (7.9 days for Group 1 and 7.1 days in Group 2; p = 0.30).
The outcomes for the two groups were similar with no significant advantage from usage of the Tri-stapler™ technology.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.